We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
126
Church & Dwight Co
CHD
$23.6B
$28.7M 0.2%
352,160
+16,265
+5% +$1.36M
TGT icon
127
Target
TGT
$66.3B
$28.5M 0.2%
186,950
+110,979
+146% +$18.2M
CAT icon
128
Caterpillar
CAT
$371B
$27.9M 0.19%
132,547
+87,151
+192% +$21.1M
EXEL icon
129
Exelixis
EXEL
$14B
$27.5M 0.19%
1,536,921
-706,117
-31% -$12.3M
GWW icon
130
W.W. Grainger
GWW
$64.7B
$27.4M 0.19%
43,216
-6,698
-13% -$4.27M
ACGL icon
131
Arch Capital
ACGL
$36.2B
$27.3M 0.19%
437,106
-169,974
-28% -$11.2M
GIS icon
132
General Mills
GIS
$20.4B
$27M 0.19%
343,405
+42,619
+14% +$3.4M
APLS
133
DELISTED
Apellis Pharmaceuticals
APLS
$26.9M 0.19%
443,507
+165,000
+59% +$9.52M
MRTX
134
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$26.2M 0.18%
764,265
-3,331
-0.4% -$150K
VZ icon
135
Verizon
VZ
$201B
$25.9M 0.18%
722,167
-277,108
-28% -$10.9M
KR icon
136
Kroger
KR
$36.9B
$25.7M 0.18%
564,644
+100,737
+22% +$4.6M
INTC icon
137
Intel
INTC
$427B
$25.6M 0.18%
851,615
+23,267
+3% +$659K
BCYC
138
Bicycle Therapeutics
BCYC
$270M
$25.5M 0.18%
1,303,211
+128,000
+11% +$3.21M
ASND icon
139
Ascendis Pharma A/S
ASND
$16.7B
$24.7M 0.17%
250,375
+60,000
+32% +$6.86M
BBY icon
140
Best Buy
BBY
$18.9B
$24.1M 0.17%
335,126
-29,078
-8% -$2.4M
ALL icon
141
Allstate
ALL
$71B
$23.7M 0.16%
232,854
-46,669
-17% -$5.9M
ANET icon
142
Arista Networks
ANET
$209B
$23.7M 0.16%
614,040
+474,016
+339% +$16.3M
XENE icon
143
Xenon Pharmaceuticals
XENE
$6.23B
$23.7M 0.16%
719,206
-16,678
-2% -$616K
BLD
144
DELISTED
TopBuild
BLD
$23.6M 0.16%
123,034
-81,657
-40% -$15.8M
PNC icon
145
PNC Financial Services
PNC
$99.9B
$23.4M 0.16%
199,996
-67,689
-25% -$10.2M
IBM icon
146
IBM
IBM
$214B
$23.3M 0.16%
193,502
-10,397
-5% -$1.39M
HCA icon
147
HCA Healthcare
HCA
$90.9B
$23.3M 0.16%
96,076
+11,961
+14% +$3.04M
URI icon
148
United Rentals
URI
$67B
$23.2M 0.16%
63,826
-2,831
-4% -$1.19M
MET icon
149
MetLife
MET
$62.7B
$22.5M 0.16%
422,288
-454,054
-52% -$30.6M
DG icon
150
Dollar General
DG
$28B
$22.4M 0.16%
115,489
+12,874
+13% +$2.89M

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.